(19)
(11) EP 2 854 625 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.11.2017 Bulletin 2017/46

(45) Mention of the grant of the patent:
04.10.2017 Bulletin 2017/40

(21) Application number: 13794119.1

(22) Date of filing: 23.05.2013
(51) International Patent Classification (IPC): 
A61B 5/02(2006.01)
A61M 5/168(2006.01)
A61B 5/00(2006.01)
A61M 5/142(2006.01)
A61M 5/145(2006.01)
(86) International application number:
PCT/US2013/042388
(87) International publication number:
WO 2013/177379 (28.11.2013 Gazette 2013/48)

(54)

OCCLUSION DETECTION

VERSTOPFUNGSERKENNUNG

DÉTECTION D'OCCLUSION


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 25.05.2012 US 201261651860 P

(43) Date of publication of application:
08.04.2015 Bulletin 2015/15

(73) Proprietor: Smiths Medical ASD, Inc.
Plymouth, MN 55442 (US)

(72) Inventors:
  • WANDER, Jacob, A.
    Minneapolis, MN 55442 (US)
  • ADAMS, Grant, A.
    Minneapolis, MN 55442 (US)
  • LACY, Christopher, A.
    Minneapolis, MN 55442 (US)

(74) Representative: Harris, Oliver John Richard 
Novagraaf UK Centrum Norwich Research Park Colney Lane
Norwich NR4 7UG
Norwich NR4 7UG (GB)


(56) References cited: : 
JP-A- H06 190 036
US-A- 5 647 853
US-A1- 2003 229 311
JP-A- 2008 264 140
US-A1- 2003 205 587
US-A1- 2003 229 311
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).